Close Menu

This newswire story reports that some watchdog groups are protesting recently published research demonstrating what may be the first time scientists genetically altered a human embryo. The scientist leading the study, Zev Rosenwaks at NewYork-Presbyterian/Weill Cornell Medical Center, says that the work centered around stem cells and that the embryo in question was chosen because it was abnormal and could never actually have developed into a viable baby.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.